RxDoctor Payments Data

Michael Horaist, MD

Colon & Rectal Surgery · Lafayette, LANPI 1922218239

Payments from drug & device makers

What this record shows

Intuitive Surgical accounts for 78.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $1,474 and has fallen 95.3% since, to $69 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in LA, where the typical reported total is $4,339.

$3,473in general payments, 2019–2025

Across 38 payments — averaging $91.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Johnson & Johnson$270
  • Biom'up France SAS$121
  • Medtronic$101
  • Biom'up SA$91
  • AbbVie$75
  • plus $90 from 3 others

What the payments were for

  • Travel & lodging$1,85153%
  • Food & beverage$1,62147%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,473 in reported general payments places this provider in the 45th percentile of 39 colon & rectal surgery providers in Louisiana.

See all colon & rectal surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$107,879
Medicare patients
169
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$5,463
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates17$1,137
CholestyramineCholestyramine (With Sugar)12$440
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen45$409
LoperamideLoperamide Hcl12$299
Neomycin Sulfate49$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$199
Metronidazole55$99
Tramadol Hcl16$33

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$270$5,46311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 39 colon & rectal surgery providers in Louisiana.

Other colon & rectal surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →